Get started
Author

Song-Yi Lee

Observed name: Song-yi Lee
ORCID: 0009-0009-8123-4100
Observed ORCID: 0009-0009-8123-4100
OpenAlex ID: A5073142902
Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al. · Cancer Discovery · 65
PDF
CDK4/6 inhibition to resensitize BRAF/EGFR inhibitor in patient-derived BRAF/PTEN-mutant colon cancer cells
2024 · Sung Hee Lim, Song-Yi Lee, et al. · Translational Cancer Research · 8
The Effect of Parental Attachment and Smart Phone Use on the College Life Adjustment of Freshmen
2014 · Tae-Eun Shim, Song-Yi Lee · Korean Journal of Family Welfare · 6
The Mediating Effect of Non-subject Activitieson the Career Adapt-Abilities of Self-Management
2016 · Song-Yi Lee, Tae-Eun Shim · Korean Journal of Family Welfare · 3
Data from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al. · 2
Data from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al. · 1
Abstract 4567: A novel PARP7 inhibitor exhibits dual antitumor activity through immune activation and tumor-intrinsic growth inhibition
2026 · Dajeong Kim, Iksoo Jang, et al. · Cancer Research
Reframing Genre and Gender in Céline Sciamma’s Tomboy
2024 · Song-Yi Lee · Journal of the Humanities
Abstract A010: Tumor-reactive T cell clonal dynamics across treatment time points drive resistance and progression to frontline chemoimmunotherapy in advanced gastric cancer
2024 · Samuel J. Wright, Minae An, et al. · Cancer Immunology Research
Figure S9 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S22 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S26 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S4 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S10 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Table S3 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Table S4 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S11 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S3 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S6 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S7 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S20 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Figure S23 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
PDF
Table S5 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Table S1 from Early Immune Remodeling Steers Clinical Response to First-Line Chemoimmunotherapy in Advanced Gastric Cancer
2024 · Minae An, Arnav Mehta, et al.
Works count: 63
Citation count: 85
H-index: 3
I10-index: 1
Year
Topic
Type